Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Embolization Products Market: By Product Type, By Embolization Type, By Therapeutic Condition, By End User, and Geography
Embolization Products Market size was valued at US$ 1,764.9 Million in 2023 and is anticipated to grow at a CAGR of 8.7% from 2024-2030. Embolization products are medical devices used in a minimally invasive procedure called embolization, which is primarily employed to block or reduce blood flow in blood vessels. The purpose of embolization is to treat a variety of medical conditions, including bleeding, vascular malformations, and tumors. Embolization involves the insertion of embolic agents or materials into the blood vessels to occlude or block them. The increasing incidence of vascular diseases is a significant driver for the growth in revenues of the embolization products market. Vascular conditions, such as aneurysms, arteriovenous malformations, and peripheral artery disease, can be life-threatening if left untreated. As per the Society for Vascular Surgery (SVS) it is stated that every year in the US 2 million people are diagnosed with an abdominal aortic aneurysm. As the occurrence of vascular diseases is on the rise, the need for effective treatment options fuels the demand for embolization products, driving revenue growth for manufacturers and suppliers in the market.
Moreover, the growing awareness of minimally invasive therapies is a significant driver behind the increased sales of embolization products. Patients and healthcare providers alike are increasingly recognizing the advantages of minimally invasive procedures, such as reduced recovery time, shorter hospital stays, and diminished post-operative pain and scarring. Embolization procedures align with this trend as they are minimally invasive by nature, involving small incisions or catheter-based approaches. However, However, regulatory hurdles for the approval of new embolization products can slow down product innovation and growth of the market. Meanwhile, collaborations between medical device manufacturers and healthcare institutions or research organizations are creating several growth opportunities for the market. The global embolization products market is surging owing to the launch of innovative products in different markets to expand the portfolio and strengthen its position in the market. For instance, in June 2023, Boston Scientific Corporation announced the FDA 510(k) clearance for the Embold Soft and Packing coils, designed for use in a variety of embolization procedures.
Study Period
2024-2030Base Year
2023CAGR
8.7%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Cardiovascular diseases (CVDs) are the disorders of the heart and blood vessels and include cerebrovascular disease, coronary heart disease, rheumatic heart disease and other conditions. The cardiac aneurysm is majorly caused due to the blockages in the aortic artery, the disease is categorized in two diseases according to the site of blockages. The rise in the prevalence of the cardiac aneurysm is growing across the world. For instance, as per the Society for Vascular Surgery (SVS) it is stated that every year in US 2 million people are diagnosed with an abdominal aortic aneurysm. It is also stated that a rupture abdominal aortic aneurysm is the 15th leading cause of death in the country. It is most commonly seen in the people older than 55 years of age.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market CAGR |
8.7% |
By Product Type |
|
By Embolization Type |
|
By Therapeutic Conditio |
|
By End User |
|
By Region |
|
Download Free Sample Report
The embolization products market size was valued at US$ 1,764.9 million in 2023. and is projected to grow at a CAGR of 8.7% from 2024 to 2030.
The key segments covered in the restless leg’s syndrome market are technology, components, application, and end-users.
The Embolization products market key player is Terumo International Systems, Stryker, Medtronic, Cerenovus (Johnson & Johnson Company), Integra Life Sciences, Blockade Medical, Adeor Surgical Instruments, Optivus Proton Therapy, Clarus Medical Systems
The growing aging global population and rising access to advanced medical procedures and technologies are some of the key opportunities for companies to enhance their revenue over the forecast years.
The development of more precise and deliverable embolization devices, including microcatheters and detachable coils stands out as a significant trend within the embolization products market.
1. Executive Summary |
2. Global Embolization Products Market Introduction |
2.1.Global Embolization Products Market - Taxonomy |
2.2.Global Embolization Products Market - Definitions |
2.2.1.Product Type |
2.2.2.Embolization Type |
2.2.3.Therapeutic Conditio |
2.2.4.End User |
2.2.5.Region |
3. Global Embolization Products Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Embolization Products Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Embolization Products Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Embolization Coils |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Microspheres or Microbeads |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Catheters |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Embolization Products Market By Embolization Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Arterial Embolization |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Chemoembolization |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Radioembolization |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Embolization Products Market By Therapeutic Conditio, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Liver Cancer |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Kidney Cancer |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Neuroendocrine Tumours |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Cardiovascular Diseases |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Uterine Fibroids |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Aneurysms |
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6.3. Market Opportunity Analysis |
7.7. Others |
7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.7.3. Market Opportunity Analysis |
8. Global Embolization Products Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Hospitals |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Clinics |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Ambulatory Surgical Centers |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Others |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9. Global Embolization Products Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10. North America Embolization Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Embolization Coils |
10.1.2.Microspheres or Microbeads |
10.1.3.Catheters |
10.2. Embolization Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Arterial Embolization |
10.2.2.Chemoembolization |
10.2.3.Radioembolization |
10.3. Therapeutic Conditio Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Liver Cancer |
10.3.2.Kidney Cancer |
10.3.3.Neuroendocrine Tumours |
10.3.4.Cardiovascular Diseases |
10.3.5.Uterine Fibroids |
10.3.6.Aneurysms |
10.3.7.Others |
10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospitals |
10.4.2.Clinics |
10.4.3.Ambulatory Surgical Centers |
10.4.4.Others |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11. Europe Embolization Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Embolization Coils |
11.1.2.Microspheres or Microbeads |
11.1.3.Catheters |
11.2. Embolization Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Arterial Embolization |
11.2.2.Chemoembolization |
11.2.3.Radioembolization |
11.3. Therapeutic Conditio Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Liver Cancer |
11.3.2.Kidney Cancer |
11.3.3.Neuroendocrine Tumours |
11.3.4.Cardiovascular Diseases |
11.3.5.Uterine Fibroids |
11.3.6.Aneurysms |
11.3.7.Others |
11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospitals |
11.4.2.Clinics |
11.4.3.Ambulatory Surgical Centers |
11.4.4.Others |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12. Asia Pacific (APAC) Embolization Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Embolization Coils |
12.1.2.Microspheres or Microbeads |
12.1.3.Catheters |
12.2. Embolization Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Arterial Embolization |
12.2.2.Chemoembolization |
12.2.3.Radioembolization |
12.3. Therapeutic Conditio Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Liver Cancer |
12.3.2.Kidney Cancer |
12.3.3.Neuroendocrine Tumours |
12.3.4.Cardiovascular Diseases |
12.3.5.Uterine Fibroids |
12.3.6.Aneurysms |
12.3.7.Others |
12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospitals |
12.4.2.Clinics |
12.4.3.Ambulatory Surgical Centers |
12.4.4.Others |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13. Middle East and Africa (MEA) Embolization Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Embolization Coils |
13.1.2.Microspheres or Microbeads |
13.1.3.Catheters |
13.2. Embolization Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Arterial Embolization |
13.2.2.Chemoembolization |
13.2.3.Radioembolization |
13.3. Therapeutic Conditio Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Liver Cancer |
13.3.2.Kidney Cancer |
13.3.3.Neuroendocrine Tumours |
13.3.4.Cardiovascular Diseases |
13.3.5.Uterine Fibroids |
13.3.6.Aneurysms |
13.3.7.Others |
13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospitals |
13.4.2.Clinics |
13.4.3.Ambulatory Surgical Centers |
13.4.4.Others |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14. Latin America Embolization Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Embolization Coils |
14.1.2.Microspheres or Microbeads |
14.1.3.Catheters |
14.2. Embolization Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Arterial Embolization |
14.2.2.Chemoembolization |
14.2.3.Radioembolization |
14.3. Therapeutic Conditio Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Liver Cancer |
14.3.2.Kidney Cancer |
14.3.3.Neuroendocrine Tumours |
14.3.4.Cardiovascular Diseases |
14.3.5.Uterine Fibroids |
14.3.6.Aneurysms |
14.3.7.Others |
14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospitals |
14.4.2.Clinics |
14.4.3.Ambulatory Surgical Centers |
14.4.4.Others |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Terumo International Systems |
15.2.2.Stryker |
15.2.3.Medtronic |
15.2.4.Cerenovus (Johnson & Johnson Company) |
15.2.5.Integra Life Sciences |
15.2.6.Blockade Medical |
15.2.7.Adeor Surgical Instruments |
15.2.8.Optivus Proton Therapy |
15.2.9.Clarus Medical Systems |
16. Research Methodology |
17. Appendix and Abbreviations |
Key Market Players